The Effect of a Single Dose of BI 1291583 on the Pharmacokinetics of a Single Dose of Dabigatran Following Oral Administration in Healthy Adult Male Subjects (an Open-label, 2- Period, Fixed-sequence Study)
Latest Information Update: 10 Mar 2025
Price :
$35 *
At a glance
- Drugs BI 1291583 (Primary) ; Dabigatran etexilate
- Indications Bronchiectasis
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 18 Feb 2025 Status changed from recruiting to active, no longer recruiting.
- 07 Feb 2025 Status changed from not yet recruiting to recruiting.
- 30 Jan 2025 New trial record